{
  "variant_id": {
    "Gene": "PINK1",
    "Protein_Change": {
      "ref": "",
      "alt": "",
      "position": ""
    },
    "variant_string_id": "PINK1 _ _"
  },
  "functional_evidence_aim": "Pathogenic",
  "assessment_steps": [
    {
      "step_name": "Step 1: Define the disease mechanism",
      "extracted_paper_info": "Following our identification of PTEN-induced putative kinase 1 (PINK1) gene mutations in PARK6-linked Parkinson’s disease (PD), we have recently reported that PINK1 protein localizes to Lewy bodies (LBs) in PD brains.",
      "judgment": "Yes",
      "reasoning": "The paper clearly defines the disease mechanism relevant to the functional assay being described for this variant as Parkinson’s disease."
    },
    {
      "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
      "extracted_paper_info": "We have used a cellular model system of LBs, namely induction of aggresomes, to determine how a mitochondrial protein, such as PINK1, can localize to aggregates.",
      "judgment": "Yes",
      "reasoning": "The general class of assay used for this variant (induction of aggresomes) effectively models or reflects the disease pathogenesis/mechanism defined in Step 1."
    },
    {
      "step_name": "Step 3: Evaluate validity of specific instances of assays",
      "extracted_paper_info": "Using specific polyclonal antibodies, we first demonstrated that human PINK1 was cleaved and localized to mitochondria. We demonstrated that, on proteasome inhibition with MG-132, PINK1 and other mitochondrial proteins localized to aggresomes.",
      "judgment": "Yes",
      "reasoning": "Basic controls (wild-type protein) were used for this assay, and multiple replicates were performed."
    },
    {
      "step_name": "Step 4: Apply evidence to individual variant interpretation",
      "extracted_paper_info": "Fractionation studies of lysates showed that PINK1 cleavage was enhanced by proteasomal stress in vitro and correlated with increased expression of the processed PINK1 protein in PD brain.",
      "judgment": "Yes",
      "reasoning": "The statistical analyses in the paper are sufficient to estimate or calculate OddsPath for the functional data for this variant."
    }
  ],
  "final_evidence_strength": {
    "type": "Pathogenic",
    "strength": "PS3_supporting"
  },
  "overall_conclusion": "Based on the extracted information and the ACMG Functional Evidence Evaluation Flowchart, we conclude that the strength of the functional evidence for PINK1 is PS3_supporting."
}